Department of Gynaecological Oncology, The Royal Marsden NHS Trust, Fulham Road, London SW3 6JJ, UK.
Eur J Surg Oncol. 2013 Aug;39(8):912-7. doi: 10.1016/j.ejso.2013.05.007. Epub 2013 May 27.
To describe the experience of laparoscopic staging of apparent early stage adnexal cancers.
Prospectively collected data on women who had laparoscopic staging for apparent early stage adnexal cancers from May 2008 to September 2012 was reviewed. All women had had a prior surgical procedure at which the diagnosis was made, without comprehensive staging. A systematic MEDLINE search from 1980 to 2012 for publications on laparoscopic staging was performed.
Thirty-five women had laparoscopic staging. Median age was 45 years (range 21-73). Median operative time was 210 min (range 90-210). Four intra-operative and one post-operative complication occurred; overall complication rate 5/35 (14%). One vena cava and one transverse colon injury underwent laparotomies for repair. Laparotomy conversion rate 2/35 (6%). Following laparoscopic staging, the cancer was upstaged for eight (23%) women; microscopic omental involvement (four women), pelvic lymph node involvement (two women), para-aortic lymph node involvement (one woman) and contra-lateral ovarian involvement (one woman). After follow up for a median of 18 months (range 3-59) the disease free survival was 94% and overall survival was 100%. Nine studies were identified on laparoscopic staging of adnexal cancer, of which this is the largest single institution series.
This study adds to the evidence that laparoscopic staging is at least as safe as staging by laparotomy with appropriate and similar oncological outcomes, but with the advantages of minimal access surgery. We therefore advocate the use of laparoscopy to achieve surgical staging for women with presumed early stage adnexal cancer.
描述腹腔镜分期疑似早期附件癌的经验。
回顾性分析 2008 年 5 月至 2012 年 9 月期间接受腹腔镜分期疑似早期附件癌的女性患者数据。所有患者均有术前诊断但未行全面分期的手术史。对 1980 年至 2012 年关于腹腔镜分期的出版物进行了系统的 MEDLINE 检索。
35 例患者接受了腹腔镜分期。中位年龄为 45 岁(范围 21-73 岁)。中位手术时间为 210 分钟(范围 90-210 分钟)。术中发生 4 例并发症,术后发生 1 例并发症;总并发症发生率为 5/35(14%)。1 例下腔静脉损伤和 1 例横结肠损伤行剖腹手术修复。剖腹手术转化率为 2/35(6%)。腹腔镜分期后,8 例(23%)癌症分期升级;4 例患者存在大网膜镜下侵犯,2 例患者存在盆腔淋巴结侵犯,1 例患者存在腹主动脉旁淋巴结侵犯,1 例患者存在对侧卵巢侵犯。中位随访 18 个月(范围 3-59 个月)后,无疾病生存率为 94%,总生存率为 100%。共检索到 9 项关于附件癌腹腔镜分期的研究,其中本研究为最大的单中心系列研究。
本研究进一步证实,腹腔镜分期与剖腹手术相比,至少同样安全,且具有相似的肿瘤学结果,但具有微创外科的优势。因此,我们提倡对疑似早期附件癌患者使用腹腔镜进行手术分期。